Wilson CH et al. |
Prospective randomised trial of the use of Daclizumab in renal transplantation using kidneys from non heart beating donors. |
2004 |
Ann. Transplant. |
pmid:15478912
|
Muraki Y et al. |
Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients. |
2011 Oct-Dec |
Ann. Transplant. |
pmid:22210422
|
Boratyńska M et al. |
Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection. |
2006 |
Ann. Transplant. |
pmid:17494290
|
Grochowiecki T et al. |
A retrospective study of steroid elimination in simultaneous pancreas and preemptive kidney transplant (Sppre-Ktx) recipients. |
2006 |
Ann. Transplant. |
pmid:17494291
|
Rhu J et al. |
Clinical Implication of Mycophenolic Acid Trough Concentration Monitoring in Kidney Transplant Patients on a Tacrolimus Triple Maintenance Regimen: A Single-Center Experience. |
2017 |
Ann. Transplant. |
pmid:29180612
|
Mocchegiani F et al. |
Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis. |
2014 |
Ann. Transplant. |
pmid:25347718
|
Fox BD et al. |
Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients. |
2017 |
Ann. Transplant. |
pmid:29133776
|
Rehman S et al. |
Effect of different tacrolimus levels on early outcomes after kidney transplantation. |
2014 |
Ann. Transplant. |
pmid:24509826
|
Legris T et al. |
Humoral immunity after kidney transplantation: impact of two randomized immunosuppressive protocols. |
2013 |
Ann. Transplant. |
pmid:24231646
|
Hakeam HA et al. |
Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients. |
2008 |
Ann. Transplant. |
pmid:18566560
|
Wu YJ et al. |
Safe One-to-One Dosage Conversion From Twice-Daily to Once-Daily Tacrolimus in Long-Term Stable Recipients After Liver Transplantation. |
2016 |
Ann. Transplant. |
pmid:26782179
|
Urbanowicz T et al. |
Induction therapy, tacrolimus plasma concentration, and duration if intensive care unit stay are risk factors for peripheral leucopenia following heart transplantation. |
2014 |
Ann. Transplant. |
pmid:25274118
|
Czubkowski P et al. |
Cardiovascular risk factors after conversion from cyclosporine to tacrolimus in children after liver transplantation. |
2014 |
Ann. Transplant. |
pmid:25409773
|
Furmańczyk A et al. |
Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation. |
2009 Oct-Dec |
Ann. Transplant. |
pmid:20009155
|
Gerlach UA et al. |
Aspergillus spondylodiscitis after multivisceral transplantation. |
2009 Oct-Dec |
Ann. Transplant. |
pmid:20009156
|
Aguiar D et al. |
Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients. |
2017 |
Ann. Transplant. |
pmid:28461684
|
Malinowski M et al. |
Effect of tacrolimus dosing on glucose metabolism in an experimental rat model. |
2010 Jul-Sep |
Ann. Transplant. |
pmid:20877268
|
Ueda K et al. |
Early corticosteroid withdrawal in the real world: a long-term analysis of kidney transplant recipients from the Mycophenolic Acid Observational Renal Transplant Registry. |
2014 |
Ann. Transplant. |
pmid:24535029
|
Miyata Y et al. |
Pharmacokinetics of a Once-Daily Dose of Tacrolimus Early After Liver Transplantation: With Special Reference to CYP3A5 and ABCB1 Single Nucleotide Polymorphisms. |
2016 |
Ann. Transplant. |
pmid:27503662
|
Mizuno S et al. |
Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients. |
2013 |
Ann. Transplant. |
pmid:23845965
|
Herden U et al. |
Early Initiation of Everolimus After Liver Transplantation: A Single-Center Experience. |
2016 |
Ann. Transplant. |
pmid:26842532
|
Kuypers DR |
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring. |
2008 |
Ann. Transplant. |
pmid:18806728
|
Grenda R et al. |
Evaluation of the genetic background of standard-immunosuppressant-related toxicity in a cohort of 200 paediatric renal allograft recipients--a retrospective study. |
2009 Jul-Sep |
Ann. Transplant. |
pmid:19644155
|
Basu A et al. |
Outcomes of renal transplantation in recipients with peak panel reactive antibody >30% under tacrolimus-based immunosuppression. |
2011 Jul-Sep |
Ann. Transplant. |
pmid:21959503
|
Fukazawa K et al. |
Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation. |
2011 Jul-Sep |
Ann. Transplant. |
pmid:21959523
|
Schmid S et al. |
Volatility of serum creatinine relative to tacrolimus levels predicts kidney transplant rejection. |
2014 |
Ann. Transplant. |
pmid:25123847
|
Remiszewski P et al. |
Orthotopic liver transplantation for acute liver failure resulting from "acute fatty liver of pregnancy". |
2003 |
Ann. Transplant. |
pmid:15114933
|
Ogura Y et al. |
Early Conversion From Twice-Daily Tacrolimus to Prolonged-Release Tacrolimus in Liver Transplantation: A Single-Center Experience. |
2016 |
Ann. Transplant. |
pmid:27432248
|
Dedinská I et al. |
Waist circumference as an independent risk factor for NODAT. |
2015 |
Ann. Transplant. |
pmid:25791039
|
Garaix F et al. |
Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study. |
2018 |
Ann. Transplant. |
pmid:30093607
|
Matia I et al. |
Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats. |
2014 |
Ann. Transplant. |
pmid:24815872
|
Gardiner KM et al. |
Multinational Evaluation of Mycophenolic Acid, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus Utilization. |
2016 |
Ann. Transplant. |
pmid:26729299
|
Park S et al. |
Reduced Tacrolimus Trough Level Is Reflected by Estimated Glomerular Filtration Rate (eGFR) Changes in Stable Renal Transplantation Recipients: Results of the OPTIMUM Phase 3 Randomized Controlled Study. |
2018 |
Ann. Transplant. |
pmid:29891834
|
Rostaing L et al. |
The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET study. |
2014 |
Ann. Transplant. |
pmid:25017487
|
Jannot M et al. |
Early conversion from twice-daily tacrolimus to once-daily extended formulation in renal transplant patients before hospital discharge. |
2014 |
Ann. Transplant. |
pmid:24999809
|
Provenzani A et al. |
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients. |
2009 Jan-Mar |
Ann. Transplant. |
pmid:19289993
|
Tang JT et al. |
A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients. |
2018 |
Ann. Transplant. |
pmid:29735966
|
Abdel Halim M et al. |
Toxic tacrolimus blood levels with rifampin administration in a renal transplant recipient. |
2010 Jan-Mar |
Ann. Transplant. |
pmid:20305320
|
Wu P et al. |
Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients. |
2011 Jan-Mar |
Ann. Transplant. |
pmid:21436775
|
Foroncewicz B et al. |
Cyclosporine is superior to tacrolimus in liver transplant recipients with recurrent psoriasis. |
2014 |
Ann. Transplant. |
pmid:25163829
|
Schnitzbauer AA et al. |
Delayed bottom-up and amended simple method of dosing with once-daily tacrolimus application to achieve stable trough levels in liver transplantation. |
2015 |
Ann. Transplant. |
pmid:25553853
|
Mahalati K and Kahan BD |
Pharmacological surrogates of allograft outcome. |
2000 |
Ann. Transplant. |
pmid:11217202
|
Garlicki M et al. |
Conversion from cyclosporine to tacrolimus improves renal function and lipid profile after cardiac transplantation. |
2006 |
Ann. Transplant. |
pmid:17025026
|
Van Laecke S et al. |
Effect of Magnesium Supplements on Insulin Secretion After Kidney Transplantation: A Randomized Controlled Trial. |
2017 |
Ann. Transplant. |
pmid:28848225
|
Malinowski M et al. |
The influence of commonly used immunosuppressive drugs on the small bowel functions - a comparative experimental study. |
2009 Apr-Jun |
Ann. Transplant. |
pmid:19487793
|
Kitazawa F et al. |
Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. |
2017 |
Ann. Transplant. |
pmid:28947731
|
Hirano Y et al. |
Prolonged Administration of Twice-Daily Bolus Intravenous Tacrolimus in the Early Phase After Lung Transplantation. |
2017 |
Ann. Transplant. |
pmid:28798289
|
Illsinger S et al. |
Effect of tacrolimus on energy metabolism in human umbilical endothelial cells. |
2011 Apr-Jun |
Ann. Transplant. |
pmid:21716189
|
Thölking G et al. |
Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation. |
2016 |
Ann. Transplant. |
pmid:27003330
|
Snell GI et al. |
Evolution to twice daily bolus intravenous tacrolimus: optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant. |
2013 |
Ann. Transplant. |
pmid:23921892
|